References:
1. Savage JA, Maize JC. Keratoacanthoma Clinical Behavior: A Systematic Review. Am J Dermatopathol. 2014;36(5):8.
2. Kwiek B, Schwartz RA. Keratoacanthoma (KA): An update and review. J Am Acad Dermatol. juin 2016;74(6):1220‑33.
3. Ko CJ, McNiff JM, Bosenberg M, Choate KA. Keratoacanthoma: Clinical and histopathologic features of regression. J Am Acad Dermatol. 2012;67(5):1008‑12.
4. Kato N, Ito K, Kimura K, Shibata M. Ferguson smith type multiple keratoacanthomas and a keratoacanthoma centrifugum marginatum in a woman from Japan. J Am Acad Dermatol. 2003;49(4):741‑6.
5. Ferguson-Smith MA, Goudie DR. Digenic/multilocus aetiology of multiple self-healing squamous epithelioma (Ferguson-Smith disease): TGFBR1 and a second linked locus. Int J Biochem Cell Biol. 2014;53:520‑5.
6. D’Alessandro M, Coats SE, Morley SM, Mackintosh L, Tessari G, Turco A, et al. Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder? J Invest Dermatol. 2007;127(10):2336‑44.
7. Goudie D. Multiple Self-Healing Squamous Epithelioma (MSSE): A Digenic Trait Associated with Loss of Function Mutations in TGFBR1 and Variants at a Second Linked Locus on the Long Arm of Chromosome 9. Genes. 2020;11(12):E1410.
8. Moss M, Weber E, Hoverson K, Montemarano AD. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2019;45(7):877‑83.
9. Nofal A, Assaf M, Ghonemy S, Nofal E, Yosef A. Generalized eruptive keratoacanthoma: a diagnostic and therapeutic challenge. Int J Dermatol. 2015;54(2):160‑7.